Relay Therapeutics RLAY

$ 4.7 0.86%

Quarterly report 2024-Q3
added 11-06-2024

Relay Therapeutics Income Statement 2011-2024 | RLAY

Annual Income Statement Relay Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.31 B	1.94 B	2.92 B	1.77 B	-	-	-	-	-	-	-	-	-
Shares	123 M	112 M	95.1 M	42.6 M	-	-	-	-	-	-	-	-	-
Historical Prices	10.7	17.3	30.7	41.6	-	-	-	-	-	-	-	-	-
Net Income	-342 M	-291 M	-364 M	-52.4 M	-75.3 M	-48.8 M	-	-	-	-	-	-	-
Revenue	25.5 M	1.38 M	3.03 M	82.7 M	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-373 M	-299 M	-365 M	-55.8 M	-84 M	-	-	-	-	-	-	-	-
Interest Expense	31 M	8.77 M	826 K	3.38 M	8.74 M	-	-	-	-	-	-	-	-
EBITDA	-368 M	-295 M	-361 M	-52.2 M	-81.2 M	-47.7 M	-	-	-	-	-	-	-
Operating Expenses	399 M	301 M	368 M	138 M	84 M	49.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	75 M	66 M	57.4 M	38.6 M	13.7 M	8.86 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Relay Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	140 M	133 M	131 M	127 M	122 M	122 M	121 M	121 M	111 M	109 M	108 M	108 M	92.7 M	91.9 M	90.2 M	89.9 M	71.2 M	4.41 M	4.15 M	4.04 M	3.56 M	3.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-88.1 M	-92.2 M	-81.4 M	-	-65.7 M	-98.5 M	-94.2 M	-	-84.2 M	-76.8 M	-62 M	-	-60.8 M	-193 M	-42.2 M	-	-36.1 M	-26.7 M	-24.9 M	-	-19.7 M	-17.5 M	-14.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	10 M	-	25.2 M	119 K	226 K	-	344 K	365 K	419 K	-	666 K	844 K	952 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-96.4 M	-101 M	-90.4 M	-	-73.6 M	-106 M	-101 M	-	-85.9 M	-77.8 M	-62.7 M	-	-61 M	-194 M	-42.4 M	-	-36.6 M	-27.7 M	-26.5 M	-	-21.9 M	-19.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	8.26 M	8.54 M	8.98 M	-	7.84 M	7.54 M	6.94 M	-	1.72 M	1.02 M	675 K	-	157 K	181 K	221 K	-	529 K	995 K	1.57 M	-	2.24 M	2.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-89 M	-	-	-	-100 M	-	-82.9 M	-77.8 M	-61.7 M	-	-58.1 M	-194 M	-41.5 M	-	-34 M	-26 M	-25.6 M	-	-19.9 M	-18.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	96.4 M	101 M	100 M	-	98.8 M	106 M	101 M	-	86.2 M	78.2 M	63.1 M	-	61.7 M	194 M	43.4 M	-	36.6 M	27.7 M	26.5 M	-	21.9 M	19.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	19.8 M	20.1 M	19.8 M	-	18.5 M	20.1 M	19.6 M	-	16.1 M	17.5 M	16.1 M	-	14.7 M	14.4 M	12.7 M	-	12.2 M	6.05 M	4.76 M	-	3.65 M	3.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency